Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Aug 16, 2020
Date Accepted: Aug 2, 2021
Date Submitted to PubMed: Dec 6, 2021

The final, peer-reviewed published version of this preprint can be found here:

A Risk-Based Clinical Decision Support System for Patient-Specific Antimicrobial Therapy (iBiogram): Design and Retrospective Analysis

Müller L, Srinivasan A, Abeles SR, Rajagopal A, Torriani FJ, Aronoff-Spencer E

A Risk-Based Clinical Decision Support System for Patient-Specific Antimicrobial Therapy (iBiogram): Design and Retrospective Analysis

J Med Internet Res 2021;23(12):e23571

DOI: 10.2196/23571

PMID: 34870601

PMCID: 8686485

iBiogram - A Risk-Based Clinical Decision Support System for Patient Specific Antimicrobial Therapy: Design and Retrospective Analysis

  • Lars Müller; 
  • Aditya Srinivasan; 
  • Shira R Abeles; 
  • Amutha Rajagopal; 
  • Francesca J Torriani; 
  • Eliah Aronoff-Spencer

ABSTRACT

Background:

Rising antimicrobial resistance poses a significant threat to public health yet current tools to direct empiric antibiotic therapy remain limited.

Objective:

To develop more precise solutions that facilitate both patient safety and population health, we identified factors influencing resistance and associated risk of treatment failure.

Methods:

We analyzed five years of susceptibility testing and patient data across a large academic medical center. We developed algorithms that mapped these data to individual cases and implemented a prototype digital empiric antimicrobial support system which we evaluated against actual prescribing outcomes.

Results:

We determined patient-specific factors across syndromes and contexts and identified relevant local patterns of antimicrobial resistance by clinical syndrome. Mortality and length of stay differed significantly depending on these factors and could be used to generate heuristic targets for acceptable risk of under-prescription. Combined with the developed “remaining risk” algorithm, these factors can be employed to inform clinicians’ reasoning. Analysis of the system showed comparable results to clinicians for low-risk diseases such as UTI, while recognizing risk and recommending better coverage in high mortality conditions such as sepsis.

Conclusions:

The application of such data-driven, patient-centered tools may guide empirical prescribing for clinicians to balance morbidity and mortality with antimicrobial stewardship.


 Citation

Please cite as:

Müller L, Srinivasan A, Abeles SR, Rajagopal A, Torriani FJ, Aronoff-Spencer E

A Risk-Based Clinical Decision Support System for Patient-Specific Antimicrobial Therapy (iBiogram): Design and Retrospective Analysis

J Med Internet Res 2021;23(12):e23571

DOI: 10.2196/23571

PMID: 34870601

PMCID: 8686485

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.